Tibolone is not an oestrogen but a mixture of a strong progestin and two weak oestrogens

This important article assesses the overall cancer risk among contemporary menopausal hormone therapy (MHT) users, based on a nationwide Swedish population –based cohort study in 290,186 women using systemic MHT from July 2005 until December 2012.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Letter to the Editor Source Type: research